<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211103052950N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-27</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of Gynecologic Laparoscopic Surgeries under Spinal Anesthesia  with General Anesthesia.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Gynecologic Laparoscopic Surgeries under Spinal Anesthesia  with General Anesthesia.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59901</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Using a table of random numbers that includes numbers from 1 to 80 with each  patient up to the 80th , we randomly select a number from the number table each time (by the random selection system of the calculator and each number will have a chance to happen only once) and according to the number displayed each patient in one of the two intervention groups (40 people And the control group (40 people) are placed in such a way that if our random number is an odd number, the patient will be in the intervention group and under spinal anesthesia, and if the random number is even, the patient in the control group will undergo general anesthesia.
Sample size: 80
Randomization from the researcher's point of view: random assignment to intervention and control groups
Description of randomization: Randomization will be done by random blocks. In this study, in order to create a balance in the number of samples assigned to each of the study groups, the block randomization method will be used. Random allocation soft ware software will be used as a randomization tool that this software In addition to randomization, it is able to generate random sequences by blocking method. For concealment, allocation concealment will be used, which is the method used to execute random sequences on study participants so that the assigned group is not known before the individual is assigned.
Assigned to study groups: Parallel, Blinding description: In this study, the anesthesiologist is completely aware of the groupings because he has to induce general anesthesia and spinal anesthesia on the patients. The same anesthesiologist and nurse collected the data during the operation and recovery, and the patient Is aware of anesthesia and only data analyzer blind to the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Comparison of laparoscopic gynecological surgeries with spinal anesthesia and general anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Control group: 40 patients will be placed under general anesthesia with induction and maintenance of anesthesia with intravenous drug propofol 1% Dongkook pharmaco made in Korea and endotracheal intubation will be performed for controlled breathing during surgery and possibility of surgery according to the pain severity, hemodynamic and respiratory consequences (such as systolic blood pressure and Diastolic, mean arterial pressure, heart rate, peripheral oxygen saturation, severity of nausea and vomiting, pain intensity) will be monitored during and after surgery. Intervention 2: Intervention group: 40 patients undergoing spinal anesthesia with spinal injection of topical anesthetic bupivacaine 5% hyperbaric aspen and the patient's spontaneous respiration will be maintained and  possibility of surgery according to the pain severity, hemodynamic and respiratory consequences (such as systolic and diastolic blood pressure, moderate pressure Arterial, heart rate, peripheral oxygen saturation, severity of nausea and vomiting, pain intensity) will be monitored during and after surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after unidentified individuals

When:
Access period starts 6 months after the results are published

To whom:
The data will be available to researchers working in academia and people in industry

Conditions:
There are no specific restrictions on the use of data or documentation

Where to obtain:
Dr.fateme tabatabaei
Drtabatabaeigyn@gmail.com

How to obtain:
Applicants will have access to the data from the present study by sending an email to the responsible author for a maximum of one week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Doctor fateme tabatabaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Army Street - Al-Zahra Hospital - Operating Room of Tabriz, East Azerbaijan Province</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138663134</zip>
        <telephone>+98 41 3476 7121</telephone>
        <email>Drtabatabaeigyn@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Doctor fateme tabatabaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Army Street - Al-Zahra Hospital - Operating Room of Tabriz, East Azerbaijan Province</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138663134</zip>
        <telephone>+98 41 3476 7121</telephone>
        <email>Drtabatabaeigyn@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female with ASA class I _ II physical condition Candidate for gynecological laparoscopic surgery in the age range of 18-60 years in Alzahra Hospital, Tabriz
Laparoscopic uterine adnexal surgeries include cystectomy, salpingectomy, oophorectomy, and ectopic pregnancy, all of which are almost identical in terms of surgery time and difficulty.
Patient consent to study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Hemoglobin less than 10
Unusual bleeding during surgery and the need for transfusions of blood and blood products
Need to convert surgery to laparotomy
Existence of any contraindications to spinal anesthesia
Sensitivity to local spinal anesthetics
Obesity
history of multiple surgeries more than twice, history of previous myomectomy,History of previous intra-abdominal adhesions
Accompanying systemic diseases such as any history of cardiovascular, pulmonary, hepatic, renal, etc.
Grade three and four gynecological surgeries include hysterectomy, resection of tubo-ovarian abscesses, advanced endometriosis, myomectomy, abdominal cerclage, resection of the lateral horn of the uterus, and any disease with intra-abdominal adhesions.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T88.59</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other complications of anesthesia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: 40 patients will be placed under general anesthesia with induction and maintenance of anesthesia with intravenous drug propofol 1% Dongkook pharmaco made in Korea and endotracheal intubation will be performed for controlled breathing during surgery and possibility of surgery according to the pain severity, hemodynamic and respiratory consequences (such as systolic blood pressure and Diastolic, mean arterial pressure, heart rate, peripheral oxygen saturation, severity of nausea and vomiting, pain intensity) will be monitored during and after surgery.</i_keyword>
      <i_keyword>Intervention group: 40 patients undergoing spinal anesthesia with spinal injection of topical anesthetic bupivacaine 5% hyperbaric aspen and the patient's spontaneous respiration will be maintained and  possibility of surgery according to the pain severity, hemodynamic and respiratory consequences (such as systolic and diastolic blood pressure, moderate pressure Arterial, heart rate, peripheral oxygen saturation, severity of nausea and vomiting, pain intensity) will be monitored during and after surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Ability to perform surgery according to the severity of pain during surgery. Timepoint: Operation time. Method of measurement: Visual analog scoring (all the time during operation, whenever the pain is more than 4 based on the analog visual score, a sedative and analgesic drug is prescribed and general anesthesia is induced if the surgery is not tolerated.).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Severe postoperative nausea and vomiting. Timepoint: Every 5 minutes in recovery until discharge from recovery and transfer to ward). Method of measurement: How to measure the variable based on scoring (0 = no nausea and vomiting, 1 = nausea, 2 = vomiting and 3 = vomiting more than 2 times.</sec_outcome>
      <sec_outcome>Severe postoperative pain. Timepoint: Recovery at 3, 6, 12, 18 and 24 hours after surgery. Method of measurement: verbal rating scale four numbers.</sec_outcome>
      <sec_outcome>Peripheral O2 saturation. Timepoint: Measurement intervals from the beginning of anesthesia every 5 minutes and in recovery until discharge every 10 minutes. Method of measurement: Pulse oximeter device.</sec_outcome>
      <sec_outcome>Heart beat. Timepoint: Measurement intervals from the beginning of anesthesia every 5 minutes and in recovery until discharge every 10 minutes. Method of measurement: Counting the heart beats per minutes.</sec_outcome>
      <sec_outcome>Mean arterial pressure. Timepoint: Measurement intervals from the beginning of anesthesia every 5 minutes and in recovery until discharge every 10 minutes. Method of measurement: Mercury barometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-25</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Golgasht St., Deputy of Research and Technology City Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
